| Product Name |
MF |
CAS |
Details |
| Atenolol
2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide |
C14H22N2O3 |
29122-68-7 |
|
| Fenticonazole Nitrate EP Impurity A
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethan-1-ol |
C11H10Cl2N2O |
24155-42-8 |
|
| Vildagliptin Chloroacetyl Nitrile (S)-Isomer
(2S)-1-(Chloroacetyl)-2-Pyrrolidinecarbonitrile ; Vildagliptin Impurity 14 |
C7H9ClN2O |
207557-35-5 |
|
| Brexpiprazole Impurity 13
4-Bromo benzo[b]thiophene |
C8H5BrS |
5118-13-8 |
|
| Pregabalin Impurity 5
3-(2-amino-2-oxoethyl)-5-methylhexanoic acid |
C9H17NO3 |
181289-15-6 |
|
| Quetiapine EP Impurity B
Quetiapine USP Related Compound B ;
Dibenzo[b,f][1,4]thiazepine-11-yl-piperazine dihydrochloride |
C17H18ClN3S |
111974-74-4 |
|
| Lenalidomide
3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6- piperidinedione |
C13H13N3O3 |
191732-72-6 |
|
| Zonisamide Related Compound A
(1,2-benzisoxazole-3-methanesulfonic acid sodium salt |
C8H8NNaO4S |
73101-64-1 |
|
| Bumetanide EP Impurity C
butyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate |
C21H28N2O5S |
32643-00-8 |
|
| Bupivacaine HCl
(2RS)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
hydrochloride |
C18H28N2O.ClH |
18010-40-7 |
|
| 4-phenyl thio benzyl chloride
(4-(chloromethyl)phenyl)(phenyl)sulfane |
C13H11ClS |
1208-87-3 |
|
| Metolazone EP Impurity E
Metolazone USP RC B ; Metolazone benzamide analog ; |
C14H14ClN3O3S |
23380-54-3 |
|
| Lacosamide
(2R)-2-(Acetylamino)-3-methoxy-N-
(phenylmethyl)propanamide |
C13H18N2O3 |
175481-36-4 |
|
| Venlafaxine EP Impurity D
Venlafaxine USP Related Compound A |
C16H25NO2 |
149289-30-5 |
|
| Pioglitazone N-Oxide
5-[[4-[2-(5-Ethyl-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-
thiazolidinedione N-oxide |
C19H20N2O4S |
145350-09-0 |
|
| Aspartame EP Impurity C
Phenylalanine |
C9H11NO2 |
150-30-1 |
|
| 3-Methylacetophenone |
C9H10O |
585-74-0 |
|
| Irbesartan Impurity C
2-[4-(Hydroxymethyl)phenyl]benzonitrile; 4-(Hydroxymethyl)-2'- cyanobiphenyl |
C14H11NO |
154709-19-0 |
|
| Ranolazine Related Compound 4
1-(2-methoxyphenoxy)-2,3- epoxy propane |
C10H12O3 |
2210-74-4 |
|
| Guaifenesin Impurity 1
2-((2-methoxyphenoxy)methyl)oxirane |
C10H12O3 |
2210-74-4 |
|
| Ranolazine Related Compound A
2-[(2-Methoxyphenoxy)methyl]oxirane |
C10H12O3 |
2210-74-4 |
|
| β-Carotene
1,3,3-Trimethyl-2-[3,7,12,16-tetramethyl-18-(2,6,6- trimethylcyclohex-1-en-1-yl) octadeca-1,3,5,7,9,11,13,15,17- nonaen-1-yl]cyclohex-1-ene |
C40H56 |
7235-40-7 |
|
| Celecoxib Related Compound 4
4,4,4-trifluoro-1-p-tolylbutane-1,3-dione |
C11H9F3O2 |
720-94-5 |
|
| Olmesartan Imidazole Ethyl Ester Impurity
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5- carboxylate |
C12H20N2O3 |
144689-93-0 |
|
| Venlafaxine EP Impurity E
(5RS)-5-(4-methoxyphenyl)-3-methyl-1-oxa-3- azaspiro[5.5]undecane |
C17H25NO2 |
93413-70-8 |
|
| Donepezil Benzyl Bromide
1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl) methyl]piperidinium bromide |
C31H36BrNO3 |
844694-85-5 |
|
| 2-Phenyl-1,3-propanediol |
C9H12O2 |
1570-95-2 |
|
| Celecoxib Impurity 7
4,4,4-trifluoro-1-(o-tolyl)butane-1,3-dione |
C11H9F3O2 |
163266-02-2 |
|
| Losartan EP Impurity D
Losartan USP RC A ; 2-Butyl-4-chloro-1H-imidazole-5- carbaldehyde |
C8H11ClN2O |
83857-96-9 |
|
| Metoprolol EP Impurity A
Metoprolol USP Related Compound A |
C14H23NO3 |
109632-08-8 |
|
| Metoprolol USP Related Compound B
(+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]- propane |
C12H17ClO3 |
56718-76-4 |
|
| Methyltestosterone
17-Hydroxy-17-methyl-3-keto-androstene-4 |
C20H30O2 |
58-18-4 |
|
| Progesterone |
C21H30O2 |
57-83-0 |
|
| 2-Butyl Benzofuran |
C12H14O |
4265-27-4 |
|
| Atorvastatin calcium salt
Calcium (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3- phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]- 3,5dihydroxyheptanoate |
C33H35FN2O5 |
134523-00-5 |
|
| Fexofenadine EP Impurity A
Fexofenadine USP related compound A |
C32H37NO4 |
76811-98-8 |
|
| Lansoprazole Sulfone N-Oxide
2-[[[3-Methyl-1-oxido-4-(2,2,2-trifluoroethoxy)-2-
pyridinyl]methyl]sulfonyl]-1H-benzimidazole |
C16H14F3N3O4S |
953787-54-7 |
|
| Leflunomide EP Impurity C
Leflunomide USP RC C ; 5-methyl-N-(3- (trifluoromethyl)phenyl)isoxazole-4-carboxamide |
C12H9F3N2O2 |
61643-23-0 |
|
| Prucalopride Succinate
4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3
-dihydrobenzofuran-7-carboxamide succinate |
C22H32ClN3O7 |
179474-85-2 |
|
| Valsartan EP Impurity C
Valsartan related compound B ; Valsartan N-Butyryl Analog |
C23H27N5O3 |
952652-79-8 |
|
| Aripiprazole Impurity 6
7-Hydroxyquinoline-(1H)-2-one , 7-Hydroxy-2(1H)-quinolinone |
C10H12Cl2N2 |
63386-61-8 |
|
| Felbamate Related Compound B
phenethyl carbamate |
C9H11NO2 |
6326-19-8 |
|
| Irbesartan Cyano Impurity
4'-[(2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3- yl)methyl]biphenyl-2-carbonitrile |
C25H27N3O |
138401-24-8 |
|
| Celecoxib Impurity 5
(E)-4-(2-(1-p-tolylethylidene)hydrazinyl)benzenesulfonamide |
C15H17N3O2S |
1061214-06-9 |
|
| Desloratadine N-Formyl Impurity
Desloratadine USP RC F; Desloratadine N-Formyl Impurity |
C20H19ClN2O |
117810-61-4 |
|
| Olmesartan Impurity 6
ethyl 4-acetyl-2-propyl-1H-imidazole-5-carboxylate |
C11H16N2O3 |
144690-07-3 |
|
| Prasugrel EP Impurity G
Prasugrel Diketone ; 1-cyclopropyl-2-(2-fluorophenyl)ethane- 1,2-dione |
C11H9FO2 |
1391054-37-7 |
|
| Telmisartan
2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl- 1H-1,3
-benzodiazol-1-yl] methyl}phenyl)benzoic acid |
C33H30N4O2 |
144701-48-4 |
|
| Atorvastatin EP Impurity F
(3R,5R)-7-[[(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)
-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-
dihydroxyheptanoyl]amino]-3,5-dihydroxyheptanoic acid |
C40H48FN3O8 |
887196-24-9 |
|
| Olmesartan Medoxomil Ethyl Methyl Analog
4-(1-Hydroxy-1-methylpropyl)-2-propyl-1-[[2’-(2H-tetrazol-5-
yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester |
C30H32N6O6 |
1378863-74-1 |
|
| Sitagliptin Impurity 18
tert-butyl (R)-(4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5- trifluorophenyl)butan-2-yl)carbamate |
C21H23F6N5O3 |
486460-23-5 |
|
| Olmesartan EP Impurity D
N2-Trityl Olmesartan Medoxomil |
C48H44N6O6 |
1020157-01-0 |
|
| Cetirizine EP Impurity Ethyl Ester
(RS)-2-[4-[(4-Chlorophenyl)phenylmethyl] piperazin-1-yl]acetic acid ethyl ester |
C21H25ClN2O2 |
19178-83-7 |
|
| Alfuzosin EP Impurity F
6,7-dimethoxy-N2,N2-dimethylquinazoline-2,4-diamine ; 4-
Amino-2-(dimethylamino)-6,7-dimethoxy-quinazoline |
C12H16N4O2 |
19216-53-6 |
|
| Memantine Related Compound A
(1r,3r,5s,7s)-1,3-dimethyladamantane |
C12H20 |
702-79-4 |
|
| Brexpiprazole Impurity 5
7,7'-(butane-1,4-diylbis(oxy))bis(quinolin-2(1H)-one) |
C22H20N2O4 |
2116542-19-7 |
|
| Progesterone EP Impurity B |
C21H32O2 |
145-14-2 |
|
| Aspartame
(S)-3-Amino-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2- yl)amino)-4-oxobutanoic acid |
C14H18N2O5 |
22839-47-0 |
|
| Lurasidone DP4- IMPURITY
Lurasidone Sulfoxide |
C28H36N4O3S |
1809325-45-8 |
|
| Pirfenidone EP Impurity C
phenol |
C6H6O |
108-95-2 |
|
| Olmesartan Medoxomil Impurity 5
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl Chloride; 4- Chloromethyl-5-methyl-2-oxo-1,3-dioxole |
C5H5ClO3 |
80841-78-7 |
|
| Hydroxychloroquine Sulfate
2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino]ethanol
Sulfate |
C18H28ClN3O5S |
747-36-4 |
|
| Cetirizine EP Impurity G
Cetirizine Ethanol Impurity ; (R)-2-(4-((4- hlorophenyl)(phenyl)methyl)piperazin-1-yl)ethan-1-ol Dihydrochloride |
C19H25Cl3N2O |
164726-80-1 |
|
| Irbesartan
2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3- diazaspiro[4.4]non-1-en-4-one |
C25H28N6O |
138402-11-6 |
|
| Loratadine EP Impurity B
Loratadine USP Related Compound C ; 8-Chloro-5,6-dihydro- 11H-benzo[5.6] cyclohepta[1,2-b]pyridin-11-one |
C14H10ClNO |
31251-41-9 |
|
| Nitroso-N-methyl-4-aminobutyric acid (NMBA)
4-(Methylnitrosoamino)butanoic Acid; N-Methyl-N-(3- carboxypropyl)nitrosamine |
C5H10N2O3 |
61445-55-4 |
|
| Dextromethorphan Impurity A
(+)-3-Methoxy morphinan; (4bR,8aR,9R)-3-Methoxy- 6,7,8,8a,9,10-hexahydro-5H-9,4b- (epiminoethano)phenanthrene |
C17H23NO |
1531-25-5 |
|
| Chlordiazepoxide EP Impurity A
Chlordiazepoxide Related Compound A (7-Chloro-1,3-dihydro-5- phenyl-2H-1,4-benzodiazepin-2-one 4-Oxide) |
C15H11ClN2O2 |
963-39-3 |
|
| Diclofenac EP Impurity A
Diclofenac USP Related Compound A;Aceclofenac EP Impurity I
; Diclofenac Amide |
C14H9Cl2NO |
15362-40-0 |
|
| Clonidine EP Impurity B
Clonidine Related Compound A ; 1-(2-((2,6- dichlorophenyl)amino)-4,5-dihydro-1H-imidazol-1-yl)ethan-1- one |
C11H11Cl2N3O |
54707-71-0 |
|
| Dabigatran Impurity 10
Dabigatran Etexilate Propanoate |
C35H43N7O5 |
1304574-20-6 |
|
| Ranolazine Related Compound C
1-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine |
C14H21N3O |
5294-61-1 |
|
| Ondansetron Hydrocloride
9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9- tetrahydro-4H-carbazol-4-one hydrochloride dihydrate |
C18H22ClN3O2 |
103639-04-9 |
|
| 1,2-Benzisoxazol-3-ylacetic Acid |
C9H7NO3 |
4865-84-3 |
|
| Metolazone 7-
Chloro-1,2,3,4-tetrahydro-2-methyl-3-(2-methylphenyl)-4-oxo-6 quinazolinesulfonamide |
C16H16ClN3O3S |
17560-51-9 |
|
| Althiazide
(3R)-3-[(Allylsulfanyl)methyl]-6-chloro-3,4-dihydro-2H-1,2,4-
benzothiadiazine-7-sulfonamide 1,1-dioxide |
C11H14ClN3O4S3 |
5588-16-9 |
|
| Febuxostat
2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5- carboxylic acid |
C16H16N2O3S |
144060-53-7 |
|
| Lacosamide EP Impurity J
Phenylmethanamine |
C7H9N |
100-46-9 |
|
| Teriflunomide ortho isomer |
|
|
|
| Bupivacaine EP Impurity A
N-(2,6-Dimethylphenyl)pyridine-2-carboxamide |
C14H14N2O |
39627-98-0 |
|
| Azilsartan Impurity 1
methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)
-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate |
C25H21N3O3 |
139481-44-0 |
|
| Dabigatran Impurity 2
N-(4-Cyanophenyl)glycine ; 2-(4-Cyanophenylamino)acetic acid |
C9H8N2O2 |
42288-26-6 |
|
| Prasugrel EP Impurity I
1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one |
C11H11FO |
150322-73-9 |
|
| Gliclazide
1-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(4- methylphenyl)sulfonyl]urea |
C15H21N3O3S |
21187-98-4 |
|
| Pirfenidone EP Impurity B
5-methylpyridin-2(1H)-one |
C6H7NO |
1003-68-5 |
|
| Atenolol EP Impurity J
2-(4-(3-amino-2-hydroxypropoxy)phenyl)acetamide |
C11H16N2O3 |
81346-71-6 |
|
| Mesalazine EP Impurity N
2-hydroxy-5-nitrobenzoic acid (5-nitrosalicylic acid). ;
Mesalamine EP Impurity N |
C7H5NO5 |
96-97-9 |
|
| Metronidazole EP impurity G
2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetic acid |
C6H7N3O4 |
1010-93-1 |
|
| Pregabalin Impurity 4/Pregabalin Impurity B
(3-Isobutylglutaric Acid) ; 3-isobutylpentanedioic acid |
C9H16O4 |
75143-89-4 |
|
| Esomeprazole EP Impurity C
Omeprazole EP Impurity C ; 5-methoxy-2-[[(4-methoxy-3,5- dimethylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole (ufiprazole) |
C17H19N3O2S |
73590-85-9 |
|
| Omeprazole EP Impurity C
Esomeprazole EP Impurity C ; Omeprazole Sulfide |
C17H19N3O2S |
73590-85-9 |
|
| Pioglitazone M1 Metabolite
5-(4-Hydroxybenzyl)-1,3-thiazolidine-2,4-dione |
C10H9NO3S |
74772-78-4 |
|
| Telmisartan Methyl Ester
2-(4-{[4-Methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)
-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid
methyl ester |
C34H32N4O2 |
528560-93-2 |
|
| Apixaban
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-
4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
C25H25N5O4 |
503612-47-3 |
|
| Candesartan EP Impurity A
Candesartan Ethyl Ester ; 2-Ethoxy-1-[[2-[1-(triphenylmethyl)
-1H-tetrazol-5-yl][1,1?-biphenyl]-4-yl]methyl]-1H- benzimidazole-7-carboxylic Acid ethyl ester |
C26H24N6O3 |
139481-58-6 |
|
| Clonidine Impurity B( Inhouse)
ethylene diamine mono-p-toluenesulfonic acid salt |
|
14034-59-4 |
|
| Elagolix sodium
4-[[(1R)-2-[5-(2-Fluoro-3-methoxyphenyl)-3-[[2-fluoro-6- (trifluoromethyl)phenyl]methyl]-3,6-dihydro-4-methyl-2,6- dioxo-1(2H)-pyrimidinyl]-1-phenylethyl]amino]butanoic acid |
C32H30F5N3O5 |
834153-87-6 |
|
| Cetirizine Methyl Ester (USP)
(RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl] ethoxy]acetic acid methyl ester dihydrochloride |
C22H27ClN2O3 |
83881-46-3 |
|
| 3-Methoxy-O-methyltyrosine |
C11H15NO4 |
55-59-4 |
|
| Brexpiprazole Impurity 15
7-(4-chloro butoxy)-1H-quinolin-2-one |
C13H14ClNO2 |
913613-82-8 |
|
